rVSV-ZEBOV-GP ring vaccination reduces the incidence of Ebola virus disease
1. In the outbreak of Ebola virus disease (EVD) in the Democratic Republic of Congo (DRC) between 2018 and 2020, ...
Tag: ebola
Vaccines for Zaire Ebola virus disease are safe and generate an immune response
1. In this trial for the safety of vaccines used to prevent Zaire Ebola virus disease (EVD), no concerns were ...
The Scan by 2 Minute Medicine®: World Mental Health Day, Beneath the Band-aid, Trouble in Uganda and Carbon Monoxide Leak Sickens Dozens!
The Scan by 2 Minute Medicine® is a new pop-culture medical newsletter designed to bring a physician perspective to trending ...
2 Minute Medicine Rewind October 16, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia In 2014, two candidate Ebola virus (EBOV) vaccines ...
Recombinant vesicular stomatitis virus vaccine elicits anti-Ebola seroconversion
1. By day 28, all recipients of a recombinant vesicular stomatitis virus (rVSV) vaccine, at each of the three doses ...
2 Minute Medicine Rewind October 17, 2016
A population-based study of cardiovascular mortality following early-stage breast cancer The disease-specific survival for women treated for early-stage breast cancer ...
Modified vaccinia Ankara booster increases immunogenic response in Ebola Virus disease
1. Chimpanzee adenovirus 3 (ChAd3) vaccination boosted with modified vaccinia Ankara (MVA) elicited superior B- and T-cell immune responses to ...
Recombinant vesicular stomatitis virus Ebola vaccine demonstrates immunogenicity
1. Zaire ebolavirus-glycoprotein-specific antibody responses were detected in all participants receiving vaccination doses from 300,000 to 50 million plaque-forming units ...
Artesunate-amodiaquine therapy linked to lower Ebola mortality
1. Artesunate-amodiaquine (AA) treated Ebola patients had a significantly lower risk of death than artemether-lumefantrine (AL) treated patients. 2. ...
Convalescent plasma transfusions may not be effective in Ebola
1. Patients with Ebola virus disease (EVD) who received convalescent plasma transfusions had a 7% less risk of mortality ...